Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Devices & Consumables > Global Recombinant Rat CDNF Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Recombinant Rat CDNF Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Recombinant Rat CDNF Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-03-11

Pages: 110 Pages

Report ld: 6168886

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global Recombinant Rat CDNF market size was US$ 94 million in 2025 and is forecast to reach a readjusted size of US$ 155 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.

Cerebral dopamine neurotrophic factor (CDNF), also known as ARMET-like protein 1, is a protein encoded by the CDNF gene and it is widely expressed in neuronal and non-neuronal tissues. The cerebral dopamine neurotrophic factor (CDNF) also is a novel neurotrophic factor with strong trophic activity on dopaminergic neurons comparable to that of glial cell line-derived neurotrophic factor (GDNF). By research, CDNF prevents the 6-hydroxydopamine (6-OHDA)-induced degeneration of dopaminergic neurons and it might be beneficial for the treatment of parkinson's disease. The human CDNF cDNA encodes a 187 aa protein with a 24 aa signal sequence and a 163 mature sequence. Mature human CDNF shares 80%, 84%, 90% and 92% aa identity with mouse, rat, equine and bovine CDNF, respectively. Although CDNF mRNA and protein are expressed in pre- and post-natal mouse brain, they are most abundant in adult heart, skeletal muscle and testis. Transcripts within the postnatal mouse brain are concentrated in the hippocampus, thalamus, corpus callosum and optic nerve.

Recombinant Rat CDNF Market Size(US$)

M= millions and B=billions

QYRLogo
In 2025, the North America Recombinant Rat CDNF market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

Major global manufacturers of Recombinant Rat CDNF include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global Recombinant Rat CDNF market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Global Recombinant Rat CDNF Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

  • Forecasted Market Size in 2032

  • US$ 155 million

  • CAGR(2026-2032)

  • 7.5%

  • Market Size Available for Years

  • 2026-2032

  • Global Recombinant Rat CDNF Companies Covered

  • Thermo Fisher Scientific Inc.

    Bio-Techne

    Scientists Helping Scientists

    Abcam Limited

    FUJIFILM Irvine Scientific

    BD Biosciences

    Bio-Rad Laboratories, Inc.

    BPS Bioscience, Inc.

    Elabscience

    Yisheng Biotechnology (Shanghai) Co., Ltd.

    Abbkine

    Beijing Biocreative Technology Co., Ltd.

    Shanghai Yaji Biotechnology Co., Ltd.

    Cellverse Co., Ltd.

    Dalian Meilun Biotech Co., Ltd.

    Sino Biological,Inc.

    Prospec-Tany Technogene Ltd

    ENZO

  • Global Recombinant Rat CDNF Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Recombinant Rat CDNF Market, Segment by Type

  • Purity＜95%

    Purity ≥95%

  • Global Recombinant Rat CDNF Market, Segment by Application

  • University

    Research Center

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Recombinant Rat CDNF sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Recombinant Rat CDNF manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Recombinant Rat CDNF product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Recombinant Rat CDNF value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Table of Contents

1 Market Overview
    1.1 Recombinant Rat CDNF Product Scope
    1.2 Recombinant Rat CDNF by Type
        1.2.1 Global Recombinant Rat CDNF Sales by Type (2021, 2025 & 2032)
        1.2.2 Purity＜95%
        1.2.3 Purity ≥95%
    1.3 Recombinant Rat CDNF by Application
        1.3.1 Global Recombinant Rat CDNF Sales Comparison by Application (2021, 2025 & 2032)
        1.3.2 University
        1.3.3 Research Center
    1.4 Global Recombinant Rat CDNF Market Estimates and Forecasts (2021-2032)
        1.4.1 Global Recombinant Rat CDNF Market Size (Value) and Growth Rate (2021-2032)
        1.4.2 Global Recombinant Rat CDNF Market Size (Volume) and Growth Rate (2021-2032)
        1.4.3 Global Recombinant Rat CDNF Price Trends (2021-2032)
    1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
    2.1 Global Recombinant Rat CDNF Market Size by Region: 2021 VS 2025 VS 2032
    2.2 Global Recombinant Rat CDNF Historical Market Scenario by Region (2021-2026)
        2.2.1 Global Recombinant Rat CDNF Sales Market Share by Region (2021-2026)
        2.2.2 Global Recombinant Rat CDNF Revenue Market Share by Region (2021-2026)
    2.3 Global Recombinant Rat CDNF Market Estimates and Forecasts by Region (2027-2032)
        2.3.1 Global Recombinant Rat CDNF Sales Estimates and Forecasts by Region (2027-2032)
        2.3.2 Global Recombinant Rat CDNF Revenue Forecast by Region (2027-2032)
    2.4 Major Regions and Emerging Market Analysis
        2.4.1 North America Recombinant Rat CDNF Market Size and Prospects (2021-2032)
        2.4.2 Europe Recombinant Rat CDNF Market Size and Prospects (2021-2032)
        2.4.3 China Recombinant Rat CDNF Market Size and Prospects (2021-2032)
        2.4.4 Japan Recombinant Rat CDNF Market Size and Prospects (2021-2032)
3 Global Market Size by Type
    3.1 Global Recombinant Rat CDNF Historical Market Review by Type (2021-2026)
        3.1.1 Global Recombinant Rat CDNF Sales by Type (2021-2026)
        3.1.2 Global Recombinant Rat CDNF Revenue by Type (2021-2026)
        3.1.3 Global Recombinant Rat CDNF Average Price by Type (2021-2026)
    3.2 Global Recombinant Rat CDNF Market Estimates and Forecasts by Type (2027-2032)
        3.2.1 Global Recombinant Rat CDNF Sales Forecast by Type (2027-2032)
        3.2.2 Global Recombinant Rat CDNF Revenue Forecast by Type (2027-2032)
        3.2.3 Global Recombinant Rat CDNF Price Forecast by Type (2027-2032)
    3.3 Representative Players for Different Types of Recombinant Rat CDNF
4 Global Market Size by Application
    4.1 Global Recombinant Rat CDNF Historical Market Review by Application (2021-2026)
        4.1.1 Global Recombinant Rat CDNF Sales by Application (2021-2026)
        4.1.2 Global Recombinant Rat CDNF Revenue by Application (2021-2026)
        4.1.3 Global Recombinant Rat CDNF Average Price by Application (2021-2026)
    4.2 Global Recombinant Rat CDNF Market Estimates and Forecasts by Application (2027-2032)
        4.2.1 Global Recombinant Rat CDNF Sales Forecast by Application (2027-2032)
        4.2.2 Global Recombinant Rat CDNF Revenue Forecast by Application (2027-2032)
        4.2.3 Global Recombinant Rat CDNF Price Forecast by Application (2027-2032)
    4.3 New Sources of Growth in Recombinant Rat CDNF Applications
5 Competition Landscape by Players
    5.1 Global Recombinant Rat CDNF Sales by Player (2021-2026)
    5.2 Global Top Recombinant Rat CDNF Players by Revenue (2021-2026)
    5.3 Global Recombinant Rat CDNF Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Recombinant Rat CDNF revenue as of 2025
    5.4 Global Recombinant Rat CDNF Average Price by Company (2021-2026)
    5.5 Global Key Manufacturers of Recombinant Rat CDNF, Manufacturing Sites & Headquarters
    5.6 Global Key Manufacturers of Recombinant Rat CDNF, Product Type & Application
    5.7 Global Key Manufacturers of Recombinant Rat CDNF, Date of Entry into This Industry
    5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
    6.1 North America Market: Players, Segments, Downstream and Major Customers
        6.1.1 North America Recombinant Rat CDNF Sales by Company
            6.1.1.1 North America Recombinant Rat CDNF Sales by Company (2021-2026)
            6.1.1.2 North America Recombinant Rat CDNF Revenue by Company (2021-2026)
        6.1.2 North America Recombinant Rat CDNF Sales Breakdown by Type (2021-2026)
        6.1.3 North America Recombinant Rat CDNF Sales Breakdown by Application (2021-2026)
        6.1.4 North America Recombinant Rat CDNF Major Customers
        6.1.5 North America Market Trends and Opportunities
    6.2 Europe Market: Players, Segments, Downstream and Major Customers
        6.2.1 Europe Recombinant Rat CDNF Sales by Company
            6.2.1.1 Europe Recombinant Rat CDNF Sales by Company (2021-2026)
            6.2.1.2 Europe Recombinant Rat CDNF Revenue by Company (2021-2026)
        6.2.2 Europe Recombinant Rat CDNF Sales Breakdown by Type (2021-2026)
        6.2.3 Europe Recombinant Rat CDNF Sales Breakdown by Application (2021-2026)
        6.2.4 Europe Recombinant Rat CDNF Major Customers
        6.2.5 Europe Market Trends and Opportunities
    6.3 China Market: Players, Segments, Downstream and Major Customers
        6.3.1 China Recombinant Rat CDNF Sales by Company
            6.3.1.1 China Recombinant Rat CDNF Sales by Company (2021-2026)
            6.3.1.2 China Recombinant Rat CDNF Revenue by Company (2021-2026)
        6.3.2 China Recombinant Rat CDNF Sales Breakdown by Type (2021-2026)
        6.3.3 China Recombinant Rat CDNF Sales Breakdown by Application (2021-2026)
        6.3.4 China Recombinant Rat CDNF Major Customers
        6.3.5 China Market Trends and Opportunities
    6.4 Japan Market: Players, Segments, Downstream and Major Customers
        6.4.1 Japan Recombinant Rat CDNF Sales by Company
            6.4.1.1 Japan Recombinant Rat CDNF Sales by Company (2021-2026)
            6.4.1.2 Japan Recombinant Rat CDNF Revenue by Company (2021-2026)
        6.4.2 Japan Recombinant Rat CDNF Sales Breakdown by Type (2021-2026)
        6.4.3 Japan Recombinant Rat CDNF Sales Breakdown by Application (2021-2026)
        6.4.4 Japan Recombinant Rat CDNF Major Customers
        6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
    7.1 Thermo Fisher Scientific Inc.
        7.1.1 Thermo Fisher Scientific Inc. Company Information
        7.1.2 Thermo Fisher Scientific Inc. Business Overview
        7.1.3 Thermo Fisher Scientific Inc. Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.1.4 Thermo Fisher Scientific Inc. Recombinant Rat CDNF Products Offered
        7.1.5 Thermo Fisher Scientific Inc. Recent Development
    7.2 Bio-Techne
        7.2.1 Bio-Techne Company Information
        7.2.2 Bio-Techne Business Overview
        7.2.3 Bio-Techne Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.2.4 Bio-Techne Recombinant Rat CDNF Products Offered
        7.2.5 Bio-Techne Recent Development
    7.3 Scientists Helping Scientists
        7.3.1 Scientists Helping Scientists Company Information
        7.3.2 Scientists Helping Scientists Business Overview
        7.3.3 Scientists Helping Scientists Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.3.4 Scientists Helping Scientists Recombinant Rat CDNF Products Offered
        7.3.5 Scientists Helping Scientists Recent Development
    7.4 Abcam Limited
        7.4.1 Abcam Limited Company Information
        7.4.2 Abcam Limited Business Overview
        7.4.3 Abcam Limited Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.4.4 Abcam Limited Recombinant Rat CDNF Products Offered
        7.4.5 Abcam Limited Recent Development
    7.5 FUJIFILM Irvine Scientific
        7.5.1 FUJIFILM Irvine Scientific Company Information
        7.5.2 FUJIFILM Irvine Scientific Business Overview
        7.5.3 FUJIFILM Irvine Scientific Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.5.4 FUJIFILM Irvine Scientific Recombinant Rat CDNF Products Offered
        7.5.5 FUJIFILM Irvine Scientific Recent Development
    7.6 BD Biosciences
        7.6.1 BD Biosciences Company Information
        7.6.2 BD Biosciences Business Overview
        7.6.3 BD Biosciences Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.6.4 BD Biosciences Recombinant Rat CDNF Products Offered
        7.6.5 BD Biosciences Recent Development
    7.7 Bio-Rad Laboratories, Inc.
        7.7.1 Bio-Rad Laboratories, Inc. Company Information
        7.7.2 Bio-Rad Laboratories, Inc. Business Overview
        7.7.3 Bio-Rad Laboratories, Inc. Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.7.4 Bio-Rad Laboratories, Inc. Recombinant Rat CDNF Products Offered
        7.7.5 Bio-Rad Laboratories, Inc. Recent Development
    7.8 BPS Bioscience, Inc.
        7.8.1 BPS Bioscience, Inc. Company Information
        7.8.2 BPS Bioscience, Inc. Business Overview
        7.8.3 BPS Bioscience, Inc. Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.8.4 BPS Bioscience, Inc. Recombinant Rat CDNF Products Offered
        7.8.5 BPS Bioscience, Inc. Recent Development
    7.9 Elabscience
        7.9.1 Elabscience Company Information
        7.9.2 Elabscience Business Overview
        7.9.3 Elabscience Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.9.4 Elabscience Recombinant Rat CDNF Products Offered
        7.9.5 Elabscience Recent Development
    7.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
        7.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
        7.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview
        7.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Rat CDNF Products Offered
        7.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development
    7.11 Abbkine
        7.11.1 Abbkine Company Information
        7.11.2 Abbkine Business Overview
        7.11.3 Abbkine Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.11.4 Abbkine Recombinant Rat CDNF Products Offered
        7.11.5 Abbkine Recent Development
    7.12 Beijing Biocreative Technology Co., Ltd.
        7.12.1 Beijing Biocreative Technology Co., Ltd. Company Information
        7.12.2 Beijing Biocreative Technology Co., Ltd. Business Overview
        7.12.3 Beijing Biocreative Technology Co., Ltd. Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.12.4 Beijing Biocreative Technology Co., Ltd. Recombinant Rat CDNF Products Offered
        7.12.5 Beijing Biocreative Technology Co., Ltd. Recent Development
    7.13 Shanghai Yaji Biotechnology Co., Ltd.
        7.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Information
        7.13.2 Shanghai Yaji Biotechnology Co., Ltd. Business Overview
        7.13.3 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.13.4 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Rat CDNF Products Offered
        7.13.5 Shanghai Yaji Biotechnology Co., Ltd. Recent Development
    7.14 Cellverse Co., Ltd.
        7.14.1 Cellverse Co., Ltd. Company Information
        7.14.2 Cellverse Co., Ltd. Business Overview
        7.14.3 Cellverse Co., Ltd. Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.14.4 Cellverse Co., Ltd. Recombinant Rat CDNF Products Offered
        7.14.5 Cellverse Co., Ltd. Recent Development
    7.15 Dalian Meilun Biotech Co., Ltd.
        7.15.1 Dalian Meilun Biotech Co., Ltd. Company Information
        7.15.2 Dalian Meilun Biotech Co., Ltd. Business Overview
        7.15.3 Dalian Meilun Biotech Co., Ltd. Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.15.4 Dalian Meilun Biotech Co., Ltd. Recombinant Rat CDNF Products Offered
        7.15.5 Dalian Meilun Biotech Co., Ltd. Recent Development
    7.16 Sino Biological,Inc.
        7.16.1 Sino Biological,Inc. Company Information
        7.16.2 Sino Biological,Inc. Business Overview
        7.16.3 Sino Biological,Inc. Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.16.4 Sino Biological,Inc. Recombinant Rat CDNF Products Offered
        7.16.5 Sino Biological,Inc. Recent Development
    7.17 Prospec-Tany Technogene Ltd
        7.17.1 Prospec-Tany Technogene Ltd Company Information
        7.17.2 Prospec-Tany Technogene Ltd Business Overview
        7.17.3 Prospec-Tany Technogene Ltd Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.17.4 Prospec-Tany Technogene Ltd Recombinant Rat CDNF Products Offered
        7.17.5 Prospec-Tany Technogene Ltd Recent Development
    7.18 ENZO
        7.18.1 ENZO Company Information
        7.18.2 ENZO Business Overview
        7.18.3 ENZO Recombinant Rat CDNF Sales, Revenue and Gross Margin (2021-2026)
        7.18.4 ENZO Recombinant Rat CDNF Products Offered
        7.18.5 ENZO Recent Development
8 Recombinant Rat CDNF Manufacturing Cost Analysis
    8.1 Recombinant Rat CDNF Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Key Suppliers of Raw Materials
    8.2 Manufacturing Cost Structure
    8.3 Manufacturing Process Analysis of Recombinant Rat CDNF
    8.4 Recombinant Rat CDNF Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
    9.1 Marketing Channels
    9.2 Recombinant Rat CDNF Distributors List
    9.3 Recombinant Rat CDNF Customers
10 Recombinant Rat CDNF Market Dynamics
    10.1 Recombinant Rat CDNF Industry Trends
    10.2 Recombinant Rat CDNF Market Drivers
    10.3 Recombinant Rat CDNF Market Challenges
    10.4 Recombinant Rat CDNF Market Restraints
11 Research Findings and Conclusion
12 Appendix
    12.1 Research Methodology
        12.1.1 Methodology/Research Approach
            12.1.1.1 Research Programs/Design
            12.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        12.1.2 Data Source
            12.1.2.1 Secondary Sources
            12.1.2.2 Primary Sources
    12.2 Author Details
    12.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Recombinant Rat CDNF Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
 Table 2. Global Recombinant Rat CDNF Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
 Table 3. Global Market Recombinant Rat CDNF Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
 Table 4. Global Recombinant Rat CDNF Sales (K Units) by Region (2021-2026)
 Table 5. Global Recombinant Rat CDNF Sales Market Share by Region (2021-2026)
 Table 6. Global Recombinant Rat CDNF Revenue (US$ Million) Market Share by Region (2021-2026)
 Table 7. Global Recombinant Rat CDNF Revenue Share by Region (2021-2026)
 Table 8. Global Recombinant Rat CDNF Sales (K Units) Forecast by Region (2027-2032)
 Table 9. Global Recombinant Rat CDNF Sales Market Share Forecast by Region (2027-2032)
 Table 10. Global Recombinant Rat CDNF Revenue (US$ Million) Forecast by Region (2027-2032)
 Table 11. Global Recombinant Rat CDNF Revenue Share Forecast by Region (2027-2032)
 Table 12. Global Recombinant Rat CDNF Sales by Type (K Units) & (2021-2026)
 Table 13. Global Recombinant Rat CDNF Sales Share by Type (2021-2026)
 Table 14. Global Recombinant Rat CDNF Revenue by Type (US$ Million) & (2021-2026)
 Table 15. Global Recombinant Rat CDNF Average Price by Type (US$/Unit) & (2021-2026)
 Table 16. Global Recombinant Rat CDNF Sales by Type (K Units) & (2027-2032)
 Table 17. Global Recombinant Rat CDNF Revenue by Type (US$ Million) & (2027-2032)
 Table 18. Global Recombinant Rat CDNF Average Price by Type (US$/Unit) & (2027-2032)
 Table 19. Representative Players of Each Type
 Table 20. Global Recombinant Rat CDNF Sales by Application (K Units) & (2021-2026)
 Table 21. Global Recombinant Rat CDNF Sales Share by Application (2021-2026)
 Table 22. Global Recombinant Rat CDNF Revenue by Application (US$ Million) & (2021-2026)
 Table 23. Global Recombinant Rat CDNF Average Price by Application (US$/Unit) & (2021-2026)
 Table 24. Global Recombinant Rat CDNF Sales by Application (K Units) & (2027-2032)
 Table 25. Global Recombinant Rat CDNF Revenue Market Share by Application (US$ Million) & (2027-2032)
 Table 26. Global Recombinant Rat CDNF Average Price by Application (US$/Unit) & (2027-2032)
 Table 27. New Sources of Growth in Recombinant Rat CDNF Applications
 Table 28. Global Recombinant Rat CDNF Sales by Company (K Units) & (2021-2026)
 Table 29. Global Recombinant Rat CDNF Sales Share by Company (2021-2026)
 Table 30. Global Recombinant Rat CDNF Revenue by Company (US$ Million) & (2021-2026)
 Table 31. Global Recombinant Rat CDNF Revenue Share by Company (2021-2026)
 Table 32. Global Recombinant Rat CDNF by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Rat CDNF as of 2025)
 Table 33. Global Market Recombinant Rat CDNF Average Price by Company (US$/Unit) & (2021-2026)
 Table 34. Global Key Manufacturers of Recombinant Rat CDNF, Manufacturing Sites & Headquarters
 Table 35. Global Key Manufacturers of Recombinant Rat CDNF, Product Type & Application
 Table 36. Global Key Manufacturers of Recombinant Rat CDNF, Date of Entry into This Industry
 Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 38. North America Recombinant Rat CDNF Sales by Company (2021-2026) & (K Units)
 Table 39. North America Recombinant Rat CDNF Sales Market Share by Company (2021-2026)
 Table 40. North America Recombinant Rat CDNF Revenue by Company (2021-2026) & (US$ Million)
 Table 41. North America Recombinant Rat CDNF Revenue Market Share by Company (2021-2026)
 Table 42. North America Recombinant Rat CDNF Sales by Type (2021-2026) & (K Units)
 Table 43. North America Recombinant Rat CDNF Sales Market Share by Type (2021-2026)
 Table 44. North America Recombinant Rat CDNF Sales by Application (2021-2026) & (K Units)
 Table 45. North America Recombinant Rat CDNF Sales Market Share by Application (2021-2026)
 Table 46. Europe Recombinant Rat CDNF Sales by Company (2021-2026) & (K Units)
 Table 47. Europe Recombinant Rat CDNF Sales Market Share by Company (2021-2026)
 Table 48. Europe Recombinant Rat CDNF Revenue by Company (2021-2026) & (US$ Million)
 Table 49. Europe Recombinant Rat CDNF Revenue Market Share by Company (2021-2026)
 Table 50. Europe Recombinant Rat CDNF Sales by Type (2021-2026) & (K Units)
 Table 51. Europe Recombinant Rat CDNF Sales Market Share by Type (2021-2026)
 Table 52. Europe Recombinant Rat CDNF Sales by Application (2021-2026) & (K Units)
 Table 53. Europe Recombinant Rat CDNF Sales Market Share by Application (2021-2026)
 Table 54. China Recombinant Rat CDNF Sales by Company (2021-2026) & (K Units)
 Table 55. China Recombinant Rat CDNF Sales Market Share by Company (2021-2026)
 Table 56. China Recombinant Rat CDNF Revenue by Company (2021-2026) & (US$ Million)
 Table 57. China Recombinant Rat CDNF Revenue Market Share by Company (2021-2026)
 Table 58. China Recombinant Rat CDNF Sales by Type (2021-2026) & (K Units)
 Table 59. China Recombinant Rat CDNF Sales Market Share by Type (2021-2026)
 Table 60. China Recombinant Rat CDNF Sales by Application (2021-2026) & (K Units)
 Table 61. China Recombinant Rat CDNF Sales Market Share by Application (2021-2026)
 Table 62. Japan Recombinant Rat CDNF Sales by Company (2021-2026) & (K Units)
 Table 63. Japan Recombinant Rat CDNF Sales Market Share by Company (2021-2026)
 Table 64. Japan Recombinant Rat CDNF Revenue by Company (2021-2026) & (US$ Million)
 Table 65. Japan Recombinant Rat CDNF Revenue Market Share by Company (2021-2026)
 Table 66. Japan Recombinant Rat CDNF Sales by Type (2021-2026) & (K Units)
 Table 67. Japan Recombinant Rat CDNF Sales Market Share by Type (2021-2026)
 Table 68. Japan Recombinant Rat CDNF Sales by Application (2021-2026) & (K Units)
 Table 69. Japan Recombinant Rat CDNF Sales Market Share by Application (2021-2026)
 Table 70. Thermo Fisher Scientific Inc. Company Information
 Table 71. Thermo Fisher Scientific Inc. Description and Business Overview
 Table 72. Thermo Fisher Scientific Inc. Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 73. Thermo Fisher Scientific Inc. Recombinant Rat CDNF Product
 Table 74. Thermo Fisher Scientific Inc. Recent Development
 Table 75. Bio-Techne Company Information
 Table 76. Bio-Techne Description and Business Overview
 Table 77. Bio-Techne Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 78. Bio-Techne Recombinant Rat CDNF Product
 Table 79. Bio-Techne Recent Development
 Table 80. Scientists Helping Scientists Company Information
 Table 81. Scientists Helping Scientists Description and Business Overview
 Table 82. Scientists Helping Scientists Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 83. Scientists Helping Scientists Recombinant Rat CDNF Product
 Table 84. Scientists Helping Scientists Recent Development
 Table 85. Abcam Limited Company Information
 Table 86. Abcam Limited Description and Business Overview
 Table 87. Abcam Limited Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 88. Abcam Limited Recombinant Rat CDNF Product
 Table 89. Abcam Limited Recent Development
 Table 90. FUJIFILM Irvine Scientific Company Information
 Table 91. FUJIFILM Irvine Scientific Description and Business Overview
 Table 92. FUJIFILM Irvine Scientific Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 93. FUJIFILM Irvine Scientific Recombinant Rat CDNF Product
 Table 94. FUJIFILM Irvine Scientific Recent Development
 Table 95. BD Biosciences Company Information
 Table 96. BD Biosciences Description and Business Overview
 Table 97. BD Biosciences Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 98. BD Biosciences Recombinant Rat CDNF Product
 Table 99. BD Biosciences Recent Development
 Table 100. Bio-Rad Laboratories, Inc. Company Information
 Table 101. Bio-Rad Laboratories, Inc. Description and Business Overview
 Table 102. Bio-Rad Laboratories, Inc. Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 103. Bio-Rad Laboratories, Inc. Recombinant Rat CDNF Product
 Table 104. Bio-Rad Laboratories, Inc. Recent Development
 Table 105. BPS Bioscience, Inc. Company Information
 Table 106. BPS Bioscience, Inc. Description and Business Overview
 Table 107. BPS Bioscience, Inc. Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 108. BPS Bioscience, Inc. Recombinant Rat CDNF Product
 Table 109. BPS Bioscience, Inc. Recent Development
 Table 110. Elabscience Company Information
 Table 111. Elabscience Description and Business Overview
 Table 112. Elabscience Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 113. Elabscience Recombinant Rat CDNF Product
 Table 114. Elabscience Recent Development
 Table 115. Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
 Table 116. Yisheng Biotechnology (Shanghai) Co., Ltd. Description and Business Overview
 Table 117. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 118. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Rat CDNF Product
 Table 119. Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development
 Table 120. Abbkine Company Information
 Table 121. Abbkine Description and Business Overview
 Table 122. Abbkine Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 123. Abbkine Recombinant Rat CDNF Product
 Table 124. Abbkine Recent Development
 Table 125. Beijing Biocreative Technology Co., Ltd. Company Information
 Table 126. Beijing Biocreative Technology Co., Ltd. Description and Business Overview
 Table 127. Beijing Biocreative Technology Co., Ltd. Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 128. Beijing Biocreative Technology Co., Ltd. Recombinant Rat CDNF Product
 Table 129. Beijing Biocreative Technology Co., Ltd. Recent Development
 Table 130. Shanghai Yaji Biotechnology Co., Ltd. Company Information
 Table 131. Shanghai Yaji Biotechnology Co., Ltd. Description and Business Overview
 Table 132. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 133. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Rat CDNF Product
 Table 134. Shanghai Yaji Biotechnology Co., Ltd. Recent Development
 Table 135. Cellverse Co., Ltd. Company Information
 Table 136. Cellverse Co., Ltd. Description and Business Overview
 Table 137. Cellverse Co., Ltd. Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 138. Cellverse Co., Ltd. Recombinant Rat CDNF Product
 Table 139. Cellverse Co., Ltd. Recent Development
 Table 140. Dalian Meilun Biotech Co., Ltd. Company Information
 Table 141. Dalian Meilun Biotech Co., Ltd. Description and Business Overview
 Table 142. Dalian Meilun Biotech Co., Ltd. Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 143. Dalian Meilun Biotech Co., Ltd. Recombinant Rat CDNF Product
 Table 144. Dalian Meilun Biotech Co., Ltd. Recent Development
 Table 145. Sino Biological,Inc. Company Information
 Table 146. Sino Biological,Inc. Description and Business Overview
 Table 147. Sino Biological,Inc. Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 148. Sino Biological,Inc. Recombinant Rat CDNF Product
 Table 149. Sino Biological,Inc. Recent Development
 Table 150. Prospec-Tany Technogene Ltd Company Information
 Table 151. Prospec-Tany Technogene Ltd Description and Business Overview
 Table 152. Prospec-Tany Technogene Ltd Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 153. Prospec-Tany Technogene Ltd Recombinant Rat CDNF Product
 Table 154. Prospec-Tany Technogene Ltd Recent Development
 Table 155. ENZO Company Information
 Table 156. ENZO Description and Business Overview
 Table 157. ENZO Recombinant Rat CDNF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 158. ENZO Recombinant Rat CDNF Product
 Table 159. ENZO Recent Development
 Table 160. Production Base and Market Concentration Rate of Raw Material
 Table 161. Key Suppliers of Raw Materials
 Table 162. Recombinant Rat CDNF Distributors List
 Table 163. Recombinant Rat CDNF Customers List
 Table 164. Recombinant Rat CDNF Market Trends
 Table 165. Recombinant Rat CDNF Market Drivers
 Table 166. Recombinant Rat CDNF Market Challenges
 Table 167. Recombinant Rat CDNF Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources


List of Figures
 Figure 1. Recombinant Rat CDNF Product Picture
 Figure 2. Global Recombinant Rat CDNF Sales (US$ Million) by Type (2021, 2025 & 2032)
 Figure 3. Global Recombinant Rat CDNF Sales Market Share by Type in 2025 & 2032
 Figure 4. Purity＜95% Product Picture
 Figure 5. Purity ≥95% Product Picture
 Figure 6. Global Recombinant Rat CDNF Sales (US$ Million) by Application (2021, 2025 & 2032)
 Figure 7. Global Recombinant Rat CDNF Sales Market Share by Application in 2025 & 2032
 Figure 8. University Examples
 Figure 9. Research Center Examples
 Figure 10. Global Recombinant Rat CDNF Sales, (US$ Million), 2021 VS 2025 VS 2032
 Figure 11. Global Recombinant Rat CDNF Sales Growth Rate (2021-2032) & (US$ Million)
 Figure 12. Global Recombinant Rat CDNF Sales (K Units) Growth Rate (2021-2032)
 Figure 13. Global Recombinant Rat CDNF Price Trends Growth Rate (2021-2032) & (US$/Unit)
 Figure 14. Recombinant Rat CDNF Report Years Considered
 Figure 15. Global Market Recombinant Rat CDNF Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
 Figure 16. Global Recombinant Rat CDNF Revenue Market Share by Region: 2021 VS 2025
 Figure 17. North America Recombinant Rat CDNF Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 18. North America Recombinant Rat CDNF Sales (K Units) Growth Rate (2021-2032)
 Figure 19. Europe Recombinant Rat CDNF Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 20. Europe Recombinant Rat CDNF Sales (K Units) Growth Rate (2021-2032)
 Figure 21. China Recombinant Rat CDNF Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 22. China Recombinant Rat CDNF Sales (K Units) Growth Rate (2021-2032)
 Figure 23. Japan Recombinant Rat CDNF Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 24. Japan Recombinant Rat CDNF Sales (K Units) Growth Rate (2021-2032)
 Figure 25. Global Recombinant Rat CDNF Revenue Share by Type (2021-2026)
 Figure 26. Global Recombinant Rat CDNF Sales Share by Type (2027-2032)
 Figure 27. Global Recombinant Rat CDNF Revenue Share by Type (2027-2032)
 Figure 28. Global Recombinant Rat CDNF Revenue Share by Application (2021-2026)
 Figure 29. Global Recombinant Rat CDNF Revenue Market Share by Application in 2021 & 2025
 Figure 30. Global Recombinant Rat CDNF Sales Share by Application (2027-2032)
 Figure 31. Global Recombinant Rat CDNF Revenue Share by Application (2027-2032)
 Figure 32. Global Recombinant Rat CDNF Sales Share by Company (2025)
 Figure 33. Global Recombinant Rat CDNF Revenue Share by Company (2025)
 Figure 34. Global 5 Largest Recombinant Rat CDNF Players Market Share by Revenue in Recombinant Rat CDNF: 2021 & 2025
 Figure 35. Recombinant Rat CDNF Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
 Figure 36. Manufacturing Cost Structure of Recombinant Rat CDNF
 Figure 37. Manufacturing Process Analysis of Recombinant Rat CDNF
 Figure 38. Recombinant Rat CDNF Industrial Chain
 Figure 39. Channels of Distribution (Direct Vs Distribution)
 Figure 40. Distributors Profiles
 Figure 41. Bottom-up and Top-down Approaches for This Report
 Figure 42. Data Triangulation
 Figure 43. Key Executives Interviewed

Description 

The global Recombinant Rat CDNF market size was US$ 94 million in 2025 and is forecast to reach a readjusted size of US$ 155 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.

Cerebral dopamine neurotrophic factor (CDNF), also known as ARMET-like protein 1, is a protein encoded by the CDNF gene and it is widely expressed in neuronal and non-neuronal tissues. The cerebral dopamine neurotrophic factor (CDNF) also is a novel neurotrophic factor with strong trophic activity on dopaminergic neurons comparable to that of glial cell line-derived neurotrophic factor (GDNF). By research, CDNF prevents the 6-hydroxydopamine (6-OHDA)-induced degeneration of dopaminergic neurons and it might be beneficial for the treatment of parkinson's disease. The human CDNF cDNA encodes a 187 aa protein with a 24 aa signal sequence and a 163 mature sequence. Mature human CDNF shares 80%, 84%, 90% and 92% aa identity with mouse, rat, equine and bovine CDNF, respectively. Although CDNF mRNA and protein are expressed in pre- and post-natal mouse brain, they are most abundant in adult heart, skeletal muscle and testis. Transcripts within the postnatal mouse brain are concentrated in the hippocampus, thalamus, corpus callosum and optic nerve.
In 2025, the North America Recombinant Rat CDNF market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

Major global manufacturers of Recombinant Rat CDNF include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global Recombinant Rat CDNF market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.

Market Segmentation
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Recombinant Rat CDNF sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Recombinant Rat CDNF manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Recombinant Rat CDNF product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Recombinant Rat CDNF value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
den_biaoTiZhungShi

Related Reports

Global Recombinant Rat CDNF Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-03-11

Pages: 110 Pages

Report ld: 6168886

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now